Managing Malabsorption: The Growing Short Bowel Syndrome Market

0
8

Short bowel syndrome (SBS) is a rare but serious condition that occurs when a significant portion of the small intestine is removed or dysfunctional, leading to malabsorption of nutrients, fluids, and electrolytes. Patients with SBS often require lifelong nutritional support, including parenteral nutrition (PN) and specialised enteral formulas, as well as medications and surgical interventions. As awareness of SBS grows and treatment options expand, the Short Bowel Syndrome Market is experiencing steady growth, driven by the critical need for effective management strategies.

The Short Bowel Syndrome Market was valued at approximately USD 5.3 billion in 2024 and is projected to reach USD 11.01 billion by 2035, growing at a CAGR of 6.87%. This growth is driven by the rising incidence of conditions that necessitate bowel resection, such as Crohn's disease and cancer, as well as advances in medical technology and nutritional support. Parenteral nutrition remains the largest treatment segment, while enteral nutrition is the fastest-growing, as healthcare shifts toward less invasive methods that promote gastrointestinal health.

Technological advancements are enhancing the management of SBS. Newer formulations of parenteral and enteral nutrition are improving patient outcomes and quality of life. Additionally, novel therapeutics, including GLP-2 analogues such as teduglutide, are reducing dependence on parenteral nutrition by promoting intestinal adaptation. As research continues to uncover new therapeutic targets and treatment approaches, the Short Bowel Syndrome Market is well-positioned for sustained growth.

People Also Ask

  • What is short bowel syndrome?
    Short bowel syndrome is a condition in which a significant portion of the small intestine is removed or dysfunctional, leading to malabsorption of nutrients and fluids.

  • How is short bowel syndrome treated?
    Treatment includes parenteral nutrition, enteral nutrition, medications such as GLP-2 analogues, and surgical interventions.

Tags: #ShortBowelSyndrome #Malabsorption #ParenteralNutrition #EnteralNutrition #RareDiseases #Gastroenterology

Search
Categories
Read More
Other
3D Printing Construction Market Scope and Forecast: From US$ 119.71M (2025) to US$ 4.9B (2034)
The global construction industry is undergoing a radical transformation as traditional...
By Sam Karan 2026-05-07 09:52:29 0 220
Other
Security Information and Event Management Market Size and Growth Forecast: Emerging Trends & Analysis
"Executive Summary Security Information and Event Management Market Market Research: Share and...
By Akash Motar 2026-03-16 17:19:15 0 798
Other
AERB License Explained: Atomic Energy Regulatory Board Compliance Made Easy
In India’s fast-changing healthcare and industrial worlds, regulatory compliance...
By Tarun Jrcompliance 2026-03-30 05:33:00 0 1K
Other
Europe FTTH GPON Market Analysis: Size, Share, Segments & Forecast
"Executive Summary Europe FTTH GPON Market Size and Share Forecast Data Bridge Market Research...
By Akash Motar 2026-03-27 11:11:13 0 727
Health
Drugs for Fatty Acid Oxidation Disorders Market – Steady Growth Across Global Healthcare Settings
Market Overview The Drugs for Fatty Acid Oxidation Disorders Market is expanding steadily as...
By Priti Mrfr 2026-08-21 09:30:04 0 108